| References |
|
|
Antoniu SA
(2011)
Therapeutic approaches in hereditary angioedema.
Clinical Reviews in Allergy and Immunology
41(1):
114–122.
|
|
|
Botto M,
Kirschfink M,
Macor P et al.
(2009)
Complement in human diseases: Lessons from complement deficiencies.
Molecular Immunology
46(14):
2774–2783.
|
|
|
Brenner P,
Keller M,
Beiras‐Fernandez A et al.
(2010)
Prevention of hyperacute xenograft rejection through direct thrombin inhibition with hirudin.
Annals of Transplantation: Quarterly of the Polish Transplantation Society
15(4):
30–37.
|
|
|
Bubeck D,
Roversi P,
Donev R et al.
(2011)
Structure of human complement C8, a precursor to membrane attack.
Journal of Molecular Biology
405(2):
325–330.
|
|
|
Carroll MC
(2004)
The complement system in regulation of adaptive immunity.
Nature Immunology
5(10):
981–986.
|
|
|
Carroll MC
(2008)
Complement and humoral immunity.
Vaccine
26(suppl. 8):
I28–I33.
|
|
|
Cianflone K,
Xia Z and
Chen LY
(2003)
Critical review of acylation‐stimulating protein physiology in humans and rodents.
Biochimica et Biophysica Acta
1609(2):
127–143.
|
|
|
Cook HT and
Botto M
(2006)
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
Nature Clinical Practice Rheumatology
2(6):
330–337.
|
|
|
Davis AE III
(2005)
The pathophysiology of hereditary angioedema.
Clinical Immunology
114(1):
3–9.
|
|
|
Degn SE,
Jensenius JC and
Thiel S
(2011)
Disease‐causing mutations in genes of the complement system.
American Journal of Human Genetics
88(6):
689–705.
|
|
|
Degn SE,
Thiel S and
Jensenius JC
(2007)
New perspectives on mannan‐binding lectin‐mediated complement activation.
Immunobiology
212(4–5):
301–311.
|
|
|
Dunkelberger JR and
Song WC
(2010)
Complement and its role in innate and adaptive immune responses.
Cell Research
20(1):
34–50.
|
|
|
Ekdahl KN,
Lambris JD,
Elwing H et al.
(2011)
Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.
Advanced Drug Delivery Reviews.
63(12):
1042–1050.
|
|
|
Forneris F,
Ricklin D,
Wu J et al.
(2010)
Structures of C3b in complex with factors B and D give insight into complement convertase formation.
Science
330(6012):
1816–1820.
|
|
|
Fridkis‐Hareli M,
Storek M,
Mazsaroff I et al.
(2011)
Design and development of TT30, a novel C3d‐targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway‐mediated diseases.
Blood
118(17):
4705–4713.
|
|
|
Garred P,
Honore C,
Ma YJ et al.
(2010)
The genetics of ficolins.
Journal of Innate Immunity
2(1):
3–16.
|
|
|
Hajishengallis G
(2010)
Complement and periodontitis.
Biochemical Pharmacology
80(12):
1992–2001.
|
|
|
Hillmen P,
Muus P,
Duhrsen U et al.
(2007)
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.
Blood
110(12):
4123–4128.
|
|
|
Kalant D,
MacLaren R,
Cui W et al.
(2005)
C5L2 is a functional receptor for acylation‐stimulating protein.
Journal of Biological Chemistry
280(25):
23936–23944.
|
|
|
Kaplan AP
(2010)
Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.
Journal of Allergy and Clinical Immunology
126(5):
918–925.
|
|
|
Kemper C,
Atkinson JP and
Hourcade DE
(2010)
Properdin: emerging roles of a pattern‐recognition molecule.
Annual Review of Immunology
28:
131–155.
|
|
|
Klos A,
Tenner AJ,
Johswich KO et al.
(2009)
The role of the anaphylatoxins in health and disease.
Molecular Immunology
46(14):
2753–2766.
|
|
|
Kotnik V
(2011)
Complement in skin diseases.
Acta dermatovenerologica Alpina, Panonica, et Adriatica
20(1):
3–11.
|
|
|
Kourtzelis I,
Markiewski MM,
Doumas M et al.
(2010)
Complement anaphylatoxin C5a contributes to hemodialysis‐associated thrombosis.
Blood
116(4):
631–639.
|
|
|
Lachmann P
(2006)
Complement before molecular biology.
Molecular Immunology
43(6):
496–508.
|
|
|
Lambris JD,
Ricklin D and
Geisbrecht BV
(2008)
Complement evasion by human pathogens.
Nature Reviews Microbiology
6(2):
132–142.
|
|
|
Le Friec G and
Kemper C
(2009)
Complement: coming full circle.
Archivum Immunologiae et Therapiae Experimentalis (Warsz)
57(6):
393–407.
|
|
|
Markiewski MM and
Lambris JD
(2007)
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
American Journal of Pathology
171(3):
715–727.
|
|
|
Markiewski MM,
DeAngelis RA and
Lambris JD
(2008)
Complexity of complement activation in sepsis.
Journal of Cellular and Molecular Medicine
12(6A):
2245–2254.
|
|
|
Markiewski MM,
Nilsson B,
Ekdahl KN,
Mollnes TE and
Lambris JD
(2007)
Complement and coagulation: strangers or partners in crime?
Trends in Immunology
28(4):
184–192.
|
|
|
Monk PN,
Scola AM,
Madala P and
Fairlie DP
(2007)
Function, structure and therapeutic potential of complement C5a receptors.
British Journal of Pharmacology
152(4):
429–448.
|
|
|
book
Morgan BP and
Harris CL
(1999)
Complement Regulatory Proteins.
San Diego: Academic Press. ISBN 978‐0‐12‐506965‐6.
|
|
|
Nilsson B,
Korsgren O,
Lambris JD and
Ekdahl KN
(2010)
Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?
Trends in Immunology
31(1):
32–38.
|
|
|
Nilsson SC,
Sim RB,
Lea SM,
Fremeaux‐Bacchi V and
Blom AM
(2011)
Complement factor I in health and disease.
Molecular Immunology
48(14):
1611–1620.
|
|
|
Nonaka M and
Kimura A
(2006)
Genomic view of the evolution of the complement system.
Immunogenetics
58(9):
701–713.
|
|
|
Nonaka M and
Yoshizaki F
(2004)
Evolution of the complement system.
Molecular Immunology
40(12):
897–902.
|
|
|
Oikonomopoulou K,
Ricklin D,
Ward PA and
Lambris JD
(2012)
Interactions between coagulation and complement – their role in inflammation.
Seminars in Immunopathology
34(1):
151–165.
|
|
|
Pangburn MK and
Muller‐Eberhard HJ
(1986)
The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.
Biochemical Journal
235(3):
723–730.
|
|
|
Pangburn MK and
Rawal N
(2002)
Structure and function of complement C5 convertase enzymes.
Biochemical Society Transactions
30(Pt 6):
1006–1010.
|
|
|
Pettigrew H,
Teuber S and
Gershwin ME
(2009)
Clinical significance of complement deficiencies.
Annals of the New York Academy of Sciences
1173:
108–123.
|
|
|
ePath Potentia
(2007) Potentia Pharmaceuticals announces initiation of Phase I clinical trials to evaluate its lead compound for age‐related macular degeneration. Potentia Press Release. http://www. potentiapharma. com/about/news. htm#17; an update of the original announcement released in 2009 can be found at: http://www.potentiapharma.com/about/news.htm#28.
|
|
|
Qu H,
Ricklin D and
Lambris JD
(2009)
Recent developments in low molecular weight complement inhibitors.
Molecular Immunology
47(2‐3):
185–195.
|
|
|
Rawal N,
Rajagopalan R and
Salvi VP
(2008)
Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
Journal of Biological Chemistry
283(12):
7853–7863.
|
|
|
Reis ES,
Falcao DA and
Isaac L
(2006)
Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H.
Scandinavian Journal of Immunology
63(3):
155–168.
|
|
|
Ricklin D and
Lambris JD
(2007)
Complement‐targeted therapeutics.
Nature Biotechnology
25(11):
1265–1275.
|
|
|
Ricklin D and
Lambris JD
(2008)
Compstatin: a complement inhibitor on its way to clinical application.
Advances in Experimental Medicine and Biology
632:
273–292.
|
|
|
Ricklin D,
Hajishengallis G,
Yang K and
Lambris JD
(2010)
Complement: a key system for immune surveillance and homeostasis.
Nature Immunology
11(9):
785–797.
|
|
|
Rittirsch D,
Flierl MA,
Nadeau BA et al.
(2008a)
Functional roles for C5a receptors in sepsis.
Nature Medicine
14(5):
551–557.
|
|
|
Rittirsch D,
Flierl MA and
Ward PA
(2008b)
Harmful molecular mechanisms in sepsis.
Nature Reviews Immunology
8(10):
776–787.
|
|
|
Silasi‐Mansat R,
Zhu H,
Popescu NI et al.
(2010)
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.
Blood
116(6):
1002–1010.
|
|
|
Skattum L,
van Deuren DM,
van der Poll T and
Truedsson L
(2011)
Complement deficiency states and associated infections.
Molecular Immunology
48(14):
1643–1655.
|
|
|
Sunyer JO and
Lambris JD
(1998)
Evolution and diversity of the complement system of poikilothermic vertebrates.
Immunological Reviews
166:
39–57.
|
|
|
Tegla CA,
Cudrici C,
Patel S et al.
(2011)
Membrane attack by complement: the assembly and biology of terminal complement complexes.
Immunology Research
51(1):
45–60.
|
|
|
Testa L,
Van Gaal WJ,
Bhindi R et al.
(2008)
Pexelizumab in ischemic heart disease: a systematic review and meta‐analysis on 15 196 patients.
Journal of Thoracic and Cardiovascular Surgery
136(4):
884–893.
|
|
|
Volanakis JE
(1989)
C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
The Year in Immunology
4:
218–230.
|
|
|
Wagner E and
Frank MM
(2010)
Therapeutic potential of complement modulation.
Nature Reviews Drug Discovery
9(1):
43–56.
|
|
|
Ward PA
(2004)
The dark side of C5a in sepsis.
Nature Reviews Immunology
4(2):
133–142.
|
|
|
Ward PA
(2009)
Functions of C5a receptors.
Journal of Molecular Medicine (Berlin)
87(4):
375–378.
|
|
|
Ward PA and
Gao H
(2009)
Sepsis, complement and the dysregulated inflammatory response.
Journal of Cellular and Molecular Medicine
13(10):
4154–4160.
|
|
|
Wu YQ,
Qu H,
Sfyroera G et al.
(2011)
Protection of nonself surfaces from complement attack by factor H‐binding peptides: implications for therapeutic medicine.
Journal of Immunology
186(7):
4269–4277.
|
|
|
Yanai R,
Thanos A and
Connor KM
(2012)
Complement involvement in neovascular ocular diseases.
Advances in Experimental Medicine and Biology
946:
161–183.
|
| Further Reading |
|
|
book
Lambris JD
(2007)
Current Topics in Innate Immunity. Advances in Experimental Medicine and Biology, vol.
598.
New York: Springer. ISBN 978‐0‐387‐71765‐4.
|
|
|
book
Lambris JD
(2008)
Current Topics in Complement II. Advances in Experimental Medicine and Biology, vol.
632.
New York: Springer. ISBN 978‐0‐387‐78951‐4.
|
|
|
book
Morikis D and
Lambris JD
(2005)
Structural Biology of the Complement System.
Florida: CRC Press. ISBN 0824725409.
|
|
|
book
Morley BJ and
Walport MJ
(2000)
The Complement FactsBook.
San Diego: Academic Press, Elsevier Ltd. ISBN: 978‐0‐12‐733360‐1.
|